National Cancer Institute - Molecular Analysis for Therapeutic Choice
Afatnib - chemocare.com
Crizotinib -chemocare.com
AZD9291 (osimertinib) cancer.gov
Dabrafenib+trametinib cancer.gov
Taselisib - cancer.gov
GSK2636771-cancer.gov
Ado-trastuzumab emtansine cancer.gov
Trametinib -chemocare.com
Defactinib -cancer.gov
Sunitinib -chemocare.com
AZD 4547 - no infor
Dasatinib (SPRYCEL)
AZD 5363
Binimetinib -cancer.gov
Palbociclib (Ibrace) -chemocare.com
Nivolumab -chemocare.com
No comments:
Post a Comment